The primary use of Levosimendan is in the management of acute decompensated heart failure when conventional therapies are inadequate. It belongs to the group of medications known as calcium sensitisers and potassium channel openers.
Additionally, Levosimendan may also be used prophylactically in cardiac surgery patients at risk of low cardiac output syndrome.
Headache
Dizziness
Low blood pressure
Faster heartbeat
Irregular heartbeat
Nausea and vomiting
Levosimendan is a calcium sensitiser and potassium channel opener.
It works by two primary mechanisms: firstly, it enhances the heart's pumping function without raising its oxygen demand. This is achieved by binding to a protein in the heart muscle called cardiac troponin C, which increases myofilaments' sensitivity to calcium. As a result, the strength of the heart's contractions improves without an increase in intracellular calcium levels.
Secondly, Levosimendan triggers vasodilation or widening of blood vessels, thereby reducing afterload. This is achieved by opening ATP-sensitive potassium channels present in the smooth muscles of blood vessels.
BDS, MDS
Bachelor of Dental Surgery
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
Frequently asked questions
No, Levosimendan is not a steroid. It is a calcium sensitiser and potassium channel opener used to manage acute heart failure.
There is no direct evidence to suggest that Levosimendan affects sleep. However, one of the common side effects of this medicine is insomnia. This means that some people may find it more difficult to sleep while taking Levosimendan.
There is generally no impact of Levosimendan on fertility. If you have concerns about fertility, it is advisable to consult with your doctor before starting this medication.
No specific dietary restrictions are required while taking Levosimendan, however, maintaining a balanced diet can generally support overall health and well-being.
Levosimendan is typically administered as a continuous intravenous infusion over a short period in the context of acute heart failure. Therefore, it would not typically be taken daily as an ongoing treatment.
Levosimendan begins to work rapidly, with effects seen within 30 minutes of starting the infusion. However, results may vary depending on individual conditions.
Levosimendan is typically administered in a controlled medical setting, rather than being taken at home at a specific time.
Company
About UsHealth ArticleHealth StoriesDiseases & Health ConditionsAll MedicinesAll BrandsNeed HelpFAQSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.7.11
Our Payment Partners